AdaptHealth Corp

On November 6, 2023, Albert Prast, the Company’s Chief Technology Officer, modified a trading arrangement he had previously adopted with respect to the sale of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) to adjust the trading terms under the plan. Mr. Prast’s initial Rule 10b5-1 Trading Plan wasadopted on March 17, 2023. Mr. Prast’s amended Rule 10b5-1 Trading Plan is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). The plan provides for the potential exercise of vested stock options and the associated sale of up to 200,000 shares of the Company's common stock pursuant to its terms. The plan expires on March 21, 2024, or upon the earlier completion of all authorized transactions under the plan.

On February 26, 2024, the Company entered into a stipulation and agreement of settlement in connection with a securities class action against the Company, its directors, and certain of its current and former officers. For further discussion, see Item 7."Management's Discussion and Analysis of Financial Condition and Results of Operations - Commitments and Contingencies."